肿瘤防治研究2023，Vol.50Issue(10)：994-998,5.DOI:10.3971/j.issn.1000-8578.2023.23.0313
贝伐珠单抗联合紫杉醇和铂类化疗对晚期转移性宫颈癌的疗效及对T淋巴细胞亚群和肿瘤标志物的影响
Efficacy of Bevacizumab Combined with Paclitaxel and Platinum-Based Chemotherapy in Advanced Metastatic Cervical Cancer and Its Effect on T Lymphocyte Subsets and Tumor Markers
摘要
关键词
转移性宫颈癌/铂类/紫杉醇/贝伐珠单抗/化疗Key words
Metastatic cervical cancer/Platinum/Paclitaxel/Bevacizumab/Chemotherapy分类
医药卫生引用本文复制引用
王利君,赵虎,袁博,方莹,王武亮..贝伐珠单抗联合紫杉醇和铂类化疗对晚期转移性宫颈癌的疗效及对T淋巴细胞亚群和肿瘤标志物的影响[J].肿瘤防治研究,2023,50(10):994-998,5.基金项目
2021 Henan Province Medical Science and Technology Tackling Program Project(No.SBGJ202103089)2021年度河南省医学科技攻关计划省部共建青年项目(SBGJ202103089) （No.SBGJ202103089）
